Zepp Health Corporation Sponsored ADR $ZEPP Shares Sold by UBS Group AG

UBS Group AG lowered its position in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) by 45.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 98,217 shares of the company’s stock after selling 83,085 shares during the quarter. UBS Group AG’s holdings in Zepp Health were worth $2,646,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Trivest Advisors Ltd acquired a new position in shares of Zepp Health during the third quarter valued at approximately $13,503,000. Keystone Investors PTE Ltd. acquired a new position in shares of Zepp Health during the third quarter valued at approximately $4,811,000. Oasis Management Co Ltd. acquired a new position in shares of Zepp Health during the third quarter valued at approximately $276,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Zepp Health in the third quarter valued at approximately $43,000. Finally, Millennium Management LLC acquired a new stake in shares of Zepp Health in the third quarter valued at approximately $11,265,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

Zepp Health Price Performance

ZEPP stock opened at $8.86 on Wednesday. The business has a fifty day moving average of $13.17 and a two-hundred day moving average of $20.54. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.28. The stock has a market cap of $130.06 million, a price-to-earnings ratio of -3.53 and a beta of 2.00. Zepp Health Corporation Sponsored ADR has a 52-week low of $2.25 and a 52-week high of $61.85.

Analyst Upgrades and Downgrades

Separately, Fundamental Research set a $56.28 price target on Zepp Health and gave the company a “buy” rating in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Zepp Health presently has an average rating of “Hold” and a consensus target price of $56.28.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.